Format

Send to

Choose Destination
J Urol. 2016 May;195(5):1421-1427. doi: 10.1016/j.juro.2015.11.055. Epub 2015 Dec 7.

Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value.

Author information

1
Department of Radiology, Ronald Reagan-UCLA Medical Center, Los Angeles, California.
2
Department of Urology, David Geffen School of Medicine, Los Angeles, California.
3
Department of Urology, David Geffen School of Medicine, Los Angeles, California; Department of Bioengineering, University of California Los Angeles, Los Angeles, California.
4
Department of Pathology, David Geffen School of Medicine, Los Angeles, California.
5
Department of Urology, David Geffen School of Medicine, Los Angeles, California. Electronic address: lmarks@mednet.ucla.edu.

Abstract

PURPOSE:

We assessed whether changes in serial multiparametric magnetic resonance imaging can help predict the pathological progression of prostate cancer in men on active surveillance.

MATERIALS AND METHODS:

A retrospective cohort study was conducted of 49 consecutive men with Gleason 6 prostate cancer who underwent multiparametric magnetic resonance imaging at baseline and again more than 6 months later, each followed by a targeted prostate biopsy, between January 2011 and May 2015. We evaluated whether progression on multiparametric magnetic resonance imaging (an increase in index lesion suspicion score, increase in index lesion volume or decrease in index lesion apparent diffusion coefficient) could predict pathological progression (Gleason 3 + 4 or greater on subsequent biopsy, in systematic or targeted cores). Diagnostic performance of multiparametric magnetic resonance imaging was determined with and without clinical data using a binary logistic regression model.

RESULTS:

The mean interval between baseline and followup multiparametric magnetic resonance imaging was 28.3 months (range 11 to 43). Pathological progression occurred in 19 patients (39%). The sensitivity, specificity, positive predictive value and negative predictive value of multiparametric magnetic resonance imaging was 37%, 90%, 69% and 70%, respectively. Area under the receiver operating characteristic curve was 0.63. A logistic regression model using clinical information (maximum cancer core length greater than 3 mm on baseline biopsy or a prostate specific antigen density greater than 0.15 ng/ml(2) at followup biopsy) had an AUC of 0.87 for predicting pathological progression. The addition of serial multiparametric magnetic resonance imaging data significantly improved the AUC to 0.91 (p=0.044).

CONCLUSIONS:

Serial multiparametric magnetic resonance imaging adds incremental value to prostate specific antigen density and baseline cancer core length for predicting Gleason 6 upgrading in men on active surveillance.

KEYWORDS:

magnetic resonance imaging; prostatic neoplasms; watchful waiting

Comment in

PMID:
26674305
PMCID:
PMC4900685
DOI:
10.1016/j.juro.2015.11.055
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center